600380 Joincare Pharmaceutical Group Industry
- 11.67
- 0.000.00%
Joincare Pharmaceutical Group Industry News
Announcement of Health Yuan Pharmaceutical Group Co., Ltd. on the independent exercise results and share changes of the company's 2022 stock options incentive plan for the first quarter of 2024
An indicative announcement by Health Yuan Pharmaceutical Group Co., Ltd. on the stock option incentive plan to limit the exercise period
Announcement of Health Yuan Pharmaceutical Group Co., Ltd. on the company's 2023 profit distribution plan
An indicative announcement by Health Yuan Pharmaceutical Group Co., Ltd. on the stock option incentive plan to limit the exercise period
Announcement of Health Yuan Pharmaceutical Group Co., Ltd. on the independent exercise results and share changes of the company\'s 2022 stock options incentive plan for the fourth quarter of 2023
Announcement of Health Yuan Pharmaceutical Group Co., Ltd. on the implementation results of share repurchase and changes in shares
Announcement of Health Yuan Pharmaceutical Group Co., Ltd. on the progress of share repurchase through centralized bidding transactions
Announcement of Health Yuan Pharmaceutical Group Co., Ltd. on the progress of share repurchase through centralized bidding transactions
Announcement of Jiankyuan Pharmaceutical Group Co., Ltd. on the independent exercise results and stock changes of the company\'s 2022 stock option incentive plan for the third quarter of 2023
An indicative announcement by Health Yuan Pharmaceutical Group Co., Ltd. on the period when the stock option incentive plan restricts the exercise of rights
Announcement of Health Yuan Pharmaceutical Group Co., Ltd. on the progress of share repurchase through centralized bidding transactions
Announcement of Health Yuan Pharmaceutical Group Co., Ltd. on the completion of registration of reservation grants for the 2022 Stock Option Incentive Plan
Announcement of Health Yuan Pharmaceutical Group Co., Ltd. on the first grant of the first exercise period in the company\'s 2022 stock option incentive plan to meet the exercise conditions
Announcement of Health Yuan Pharmaceutical Group Co., Ltd. on the fulfillment of the exercise conditions for the first exercise period granted for the first time in the company\'s 2022 stock option incentive plan
Health Source Pharmaceutical Group Co., Ltd.\'s list of incentive recipients for the first time granted the first exercise period in the 2022 Stock Option Incentive Plan
Indicative announcement of Jiankyuan Pharmaceutical Group Co., Ltd. on adopting an autonomous exercise model for the first exercise period granted in the company\'s 2022 stock option incentive plan
Announcement of Health Yuan Pharmaceutical Group Co., Ltd. on the completion of cancellation of 2022 stock options for some companies that have been granted rights yet to exercise
Legal opinion of Beijing Zhonglun Law Firm on the fulfillment of exercise conditions for the first time a stock option granted by the 2022 Stock Option Incentive Plan of Health Yuan Pharmaceutical Group Co., Ltd. for the first time
Announcement of Health Yuan Pharmaceutical Group Co., Ltd. on the progress of share repurchase through centralized bidding transactions
Legal Opinion of Beijing Zhonglun Law Firm on the cancellation of part of the 2022 Stock Option Incentive Plan by Health Yuan Pharmaceutical Group Co., Ltd. on the granting of stock options that have not yet been exercised and the granting of reserved stoc
Analysis
Price Target
No Data
